Curative Biotechnology, Inc. Stock Other OTC
Equities
CTYX
US20786Q2093
Biotechnology & Medical Research
Financials (USD)
Sales 2020 | - | Sales 2021 | - | Capitalization | 29.41M |
---|---|---|---|---|---|
Net income 2020 | -4M | Net income 2021 | -5M | EV / Sales 2020 | - |
Net Debt 2020 | 399K | Net cash position 2021 | 670K | EV / Sales 2021 | - |
P/E ratio 2020 |
-2.11
x | P/E ratio 2021 |
-1.44
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 99.95% |
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 21-02-10 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 22-05-11 |
Theresa Heah
BRD | Director/Board Member | 46 | Mar. 30 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+3.13% | 43.43B | |
+48.49% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+1.58% | 12.33B | |
+32.83% | 12.59B | |
+6.63% | 11.03B |